HF
EVGN icon

HRT Financial’s Evogene EVGN Stock Holding History

HRT Financial’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45K Buy
+107,198
New +$74.2K ﹤0.01% 3795
2023
Q4 		– Sell
-1,521
Closed -$8K – 2518
2023
Q3 		$8K Buy
+1,521
New +$13.3K ﹤0.01% 2140
2022
Q1 		– Sell
-1,345
Closed -$22K – 3298
2021
Q4 		$22K Buy
+1,345
New +$30.5K ﹤0.01% 2938
2021
Q2 		– Sell
-1,504
Closed -$75K – 3022
2021
Q1 		$75K Buy
+1,504
New +$93.1K ﹤0.01% 2492

Other funds holding EVGN

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.45B AUM

HRT Financial's EVGN Position: Q2 2026 in Review

HRT Financial opened a new position in Evogene (EVGN) in Q2 2026: 107,198 shares worth $45K. The stake represents ﹤0.01% of the portfolio and ranks #3795 among its holdings. This is a return to the name: HRT Financial previously reported a position in EVGN as recently as Q3 2023.

HRT Financial first reported a position in EVGN in Q1 2021 and has held it in 4 quarters since. The position peaked at $75K in Q1 2021. 13 funds tracked by Wall St. Rank hold EVGN as of Q2 2026.

  • HRT Financial held 107,198 shares of Evogene worth $45K as of Q2 2026.
  • Evogene was a new HRT Financial position in Q2 2026.
  • Evogene made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3795 holding.
  • HRT Financial first reported a position in Evogene in Q1 2021 and has held it in 4 quarters since.
  • HRT Financial's Evogene position peaked at $75K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Evogene as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.